Enterprise League logo

Biotechnology Companies in Europe

Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 480 companies in this sector. The largest share of listings is based in London. Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
480 companies
London top city

Europe
Biotechnology
List of Biotechnology companies in Europe

480 companies

Sort by

At Biomage, we are deeply passionate about the goal of improving human health. We are achieving this goal by creating a single cell analytics platform, Cellscope, which empowers researchers to gain unprecedented insight into complex datasets, discover new drug targets and answer deep biological questions. We take away technical difficulties and bring clarity to 'big data' using accessible and intuitive tools. Cellscope enables the research biologist to analyse their datasets without the need for bioinformatics expertise. Its user friendly interface and intuitive software empowers researchers to take ownership of their single cell analysis, generating biological insight in just a few clicks. * For academic users it's free - sign up at https://www.biomage.net/signup * If you’re looking to become an industry partner, visit https://www.biomage.net/partnerships or reach out to our CEO: Adam@biomage.net Discover. One cell at a time.
Software
Data Visualization
Biotechnology
Life Science

2019

Blue Planet Ecosystems builds, develops and operates modular LARA (Land-based Automated Recirculating Aquaculture) systems for sustainable seafood production in extreme environments. We help farmers, agriculture businesses and future entrepreneurs to diversify their farming methods in the face of climate change.
Food Vendors
Biotechnology
Agriculture

2018

EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.
Clinical Trials
Healthcare
Biotechnology
Life Science

2017

We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases
Manufacturing
Pharmaceutical
Healthcare
Biotechnology
Life Science

2016

The insect technology company • Our mission is to accelerate a global transition to sustainable protein.
Biotechnology
CleanTech
AgTech
Agriculture

2015

Bionomous combines innovative micro-engineering design and artificial intelligence to automatically inspect and sort miniature biological entities. Our technology was originally developed to handle the eggs of zebrafish (Danio rerio), but it can handle any round entity ranging from 0.6 to 1.5 mm. It has been used to sort xenopus oocytes and embryos, killifish eggs, and even seeds!
Machine learning
Biotechnology

2019

Recolony is a Swiss biotech start-up with the goal of developing a bacteria-based oral therapy to treat and prevent cancer.
Biotechnology

2022

KINOKO LABS is becoming BOSQUE FOODS ! We are excited to present our new brand and looking forward to showcase our first products soon. At Bosque Foods, we envision a world in which our future generations can prosper and thrive, without compromising the health of our planet. Our mission is to create better-than-meat products that deliver on the entire taste experience, nutrition, and price of traditional meat without compromise. Our solution is to create the best clean-image, minimally processed whole-cut meat and fish alternatives grown naturally from fungal mycelium.
Food Vendors
Biotechnology

2020

We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.
Wellness and Spa
Exercise and Fitness
Healthcare
Biotechnology

2015

By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. Our mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.
Biotechnology

2019

CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.
Artificial Intelligence
Biotechnology
Life Science

2021

Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical candidate from Crescendo’s T cell enhancing pipeline. Crescendo is also developing CB213, a preclinical PD-1 x LAG-3 multi-specific Humabody. The Company’s ability to develop multi-functional Humabody therapeutics is based on its unique, patent protected, transgenic mouse platform generating fully human VH domain building blocks (Humabody VH). These robust molecules can be configured to engage therapeutic targets in such a way that they deliver novel pharmacology and superior bio-distribution. This can lead to larger therapeutic windows compared to conventional IgG approaches. Humabody-based formats can also be applied across a range of non-cancer indications. Beyond Crescendo’s proprietary pipeline, the Company has global, multi-target discovery and development collaborations with both Takeda and BioNTech and an exclusive, worldwide licensing agreement with Zai Lab for ZL-1102 (formerly CB001, an anti-IL-17A targeting Humabody), which is expected to enter global Phase 2 clinical development in patients with psoriasis. Crescendo Biologics is located in Cambridge, UK, and is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda and Quan Capital. For more information, please visit www.crescendobiologics.com.
Healthcare
Biotechnology
Therapeutics

2009

Providing predictive analytics from suspended-cells through our unbiased cytometry technology, Cytomos® Dielectric Spectroscopy: CDS™
Machine learning
Medical
Biopharma
Biotechnology

2012

In Deepflare, we are developing tools never to be scared about viruses and diseases. We were established in 2020 with the simple goal of using AI to combat the problem of virus mutation. We build systems to help pharmaceutical companies develop better, more effective vaccines faster.
Artificial Intelligence
Biotechnology

2022

As Spinoff of TNO, we develop integrated photonics to create highly sensitive and selective biosensors. These are an order of magnitude more affordable, measure multiple biomarkers and are extremely sensitive, reaching SPR sensitivity. Our chips and readout device can be used anywhere from medical research, agriculture to Point-of-Care diagnostic applications.
Biotechnology

2018

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. * Posts here are for information only without any warranty of any kind.
Pharmaceutical
Biotechnology
Neuroscience

2016

AFYX Therapeutics is a private biopharmaceutical company focused on innovative approaches to treat mucosal diseases. The Company has developed the Rivelin patch, a breakthrough therapy for the treatment of mucosal diseases. Rivelin is designed to deliver a pharmaceutical drug uni-directionally to a mucosal surface using an occlusive, bio-adhesive and bio-degradable patch, with a long adhesion time and a high flexibility, conforming to the mucosal surface. AFYX's lead Rivelin patch product candidate seeks to treat the auto-immune, inflammatory disease oral lichen planus (OLP) through direct delivery of the drug clobetasol propionate. OLP may appear as lesions in the mouth that may cause burning, pain and other discomfort. OLP is considered an autoimmune disorder and requires regular monitoring given patients have increased risk of developing mouth cancer in the affected areas. No U.S. Food and Drug Administration (FDA) approved treatment exists, with today’s off-label treatment ranging from topical corticosteroids to laser ablation. It is estimated that OLP affects 1% to 2% of the population. Following successful results from a Phase 1b clinical study of the non-drug-loaded Rivelin patch in patients with OLP, AFYX has begun a Phase 2b clinical study of the clobetasol-loaded Rivelin patch in the United States and various countries in Europe. Shareholders include Sofinnova Ventures, Lundbeckfonden Emerge, Novo Seeds and Welfare Tech Invest.
Shipping and Delivery
Pharmaceutical
Clinical Trials
Healthcare
Biotechnology
Therapeutics

2024

Emulseo is a startup company dedicated to the design and production of high-quality formulations for microfluidic applications. Our service is based upon long-term know-how and expertise in the field of microfluidics for pharmaceutical, biotech and chemical industry. Check out our website to discover our choice of fluorinated surfactants, fluorinated oils, surface treatments and many more products to come! Whatever your application, we have a dedicated team of scientists focused on working closely with you to provide products and custom-made solutions of the highest quality and guide you through your projects.
Manufacturing
Pharmaceutical
Biotechnology

2018

Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques.
Fashion Accessories
Fashion Design
Advanced Materials
GreenTech
Biotechnology

2021

FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs.
Medical Equipment and Services
Health and Medical Products
Medical
Healthcare
Biotechnology
Therapeutics

2014

Electrical Impedance Tomography is a non-invasive, radiation-free imaging modality. Kite Medical is developing a novel device to detect kidney reflux in children. The non-invasive diagnostic solution for kidney reflux removes the trauma and the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children. It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure. Early diagnosis is vital, but current standard tests involve catheterisation, filling the bladder with contrast agent and multiple xray images. The Kite solution is a cost-effective, patient centric alternative, non-invasive and radiation-free ideal for screening and monitoring of these patients.
Medical Equipment and Services
Health and Medical Products
Medical
Healthcare
Biotechnology

2016

LIVIN farms empower people to co-create a healthy planet through the development of insect rearing technology. We are currently working on exciting projects in professional insect breeding.
Food Processing
Sustainability
Biotechnology

2015

Genkyotex has become a wholly owned subsidiary of Calliditas and have been delisted from the Euronext stock exchanges. Genkyotex’s lead product candidate, setanaxib, is a first-in-class NOX inhibitor that targets NOX 1 and NOX 4, which are major drivers of fibrogenesis in multiple organs. In Q4 2021, Calliditas plans to initiate a 52-week, randomized, placebo-controlled, double-blind, trial with an adaptive phase 2b/3 design with setanaxib in 318 patients with primary biliary cholangitis (PBC). As previously announced in August 2021, Calliditas received FDA fast track designation for setanaxib in PBC. Calliditas will also initiate a Phase 2 proof-of-concept study in head and neck cancer in 2021, which will investigate the administration of setanaxib in conjunction with immunotherapy targeting cancer associated fibroblasts (CAFs). Follow @Calliditas Therapeutics for updates on future developments: https://www.linkedin.com/company/calliditas-therapeutics/
Pharmaceutical
Healthcare
Biotechnology

2006

Rome-based healthtech startup that offers with JuliaOmix™ an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp has developed several bioinformatics tools and protocols to make data and metadata - today big health data - traceable, accessible, interoperable and reusable, necessary for researchers and clinicians who want to give an answer to the millions of people who face the odyssey of the diagnosis of a genetic disease, even more so if rare
Artificial Intelligence
Software
Medical
Healthcare
Biotechnology
Genetics

2017

GH Research is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Pharmaceutical
Biopharma
Biotechnology

2018

GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions.
Healthcare
Biotechnology

2016

GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation. GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures.
Biotechnology

2017

Auto-transfusion specialist through innovative technology for the separation of blood components.
Biotechnology

2015

Lightcast is developing a cell manipulation platform that utilises tiny spots of light to control thousands of cells and reagents at once, enabling game-changing workflows for the pharmaceutical industry. With applications ranging from immuno-oncology to antibody discovery, stem cell production, cell therapy, and cell line development, the Lightcast platform offers unprecedented levels of control. As Lightcast grows, we’re excited to invite more people to join us on our mission to revolutionise complex cell analysis. If life at Lightcast appeals to you check out the jobs, we currently have available and become a part of something truly meaningful!
Biotechnology

2019

In Lignopure we produce natural degradable biopolymers from non-food sources. Our Lignopure product is the best-of-its-kind lignin, with proven non cytotoxicity and added functionality. No other lignin in the market can offer the safety of Lignopure and the tailored properties achieved through our protected technology. From the raw material production, we are able to deliver tailored lignin for different applications; these include particles for cosmetics, pharmaceuticals and food supplements. Additionally, our biobased prototypes include insulating materials, biobased polyurethane foams, aerogels and filaments for 3D printing. GO GREEN!
Manufacturing
Biotechnology

2019

CardioRenal uses the advanced technologies to develop digital therapeutic solutions.
Medical Equipment and Services
Medical
Healthcare
Biotechnology
Therapeutics

2013

Ziccum's ambient drying technology LaminarPace opens up unique thermostable formulation possibilities for next-generation biomolecules - from vaccines to protein therapeutics.
Pharmaceutical
Biotechnology

2017

Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™ technology platform we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind. Our lead product was designed to balance potent anti-tumor immunity with a desirable safety profile by targeting 4-1BB, PD-L1 and Human Serum Albumin simultaneously. We believe meeting the highest quality standards in every step of the drug design process matters and will result in better patient outcomes.
Biotechnology

2011

Luminate Medical is a healthcare technology company that builds devices to prevent and control the side effects of cancer treatment. Based in Galway, Ireland, Luminate is pioneering the development of Lily, a device to prevent chemotherapy induced hair loss in a comfortable and portable way, and Lilac, the world's first preventative treatment for peripheral neuropathy. Luminate is a VC-backed startup funded by Y Combinator (S21) with multiple successful grant and investment rounds to date.
Medical Equipment and Services
Health and Medical Products
Medical
Healthcare
Biotechnology

2018

Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands.
Medical Equipment and Services
Health and Medical Products
Medical
Emergency Medicine
Healthcare
Biotechnology

2008

MaxiVAX SA is a clinical stage (Phase II) biotech company dedicated to the cure of cancer by immuno-therapy. Its treatment is capable of stimulating the natural immune response of the patient to eliminate cancer cells. Phase I clinical trials were completed with no safety issue, were well tolerated and with encouraging efficacy data. The company received the 2017 CTI Swiss Medtech Award for its ground-breaking work, and its lead product, MVX-ONCO-1, which is in Phase 2 development for Head & Neck cancer in Switzerland. The company successfully filed an IND with the US FDA in 2018.
Biotechnology

2005

Medicilio brings healthcare to patients's homes.
Medical Professionals
Mental Health Care
Medical Organisations
Medical
Healthcare
Biotechnology

2020

Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants. For further information, please visit: medicrea.com
IT Services
Medical Equipment and Services
Health and Medical Products
IT Consulting Services
Medical
Healthcare
Biotechnology

1990

MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare
Medical Equipment and Services
Health and Medical Products
IT Consulting Services
Medical
CRM
Healthcare
Biotechnology

2014

MiAlgae aims to revolutionize the current livestock and pet feed industries by producing microalgae rich in polyunsaturated fatty acids (PUFAs) to offer as a replacement to fishmeal in feed. 🚫🐟 Feed suppliers are in need of this alternative to fishmeal due to declining wild fish stocks and rising demand for Omega-3s. MiAlgae has developed an environmentally beneficial, effective, and simple solution of producing microalgae which delivers the required nutrients to livestock and pets without the need for fish. ♻️ Our zero-waste solution recycles the nutritional co-products from whisky production to grow Omega-3 rich microalgae, returning clean water in the process. 🌍 Our mission is to create a product that will contribute substantially towards the sustainable production of livestock, a prerequisite to fulfilling the needs of the growing world population. 💡Please check us out and follow us on: -https://www.twitter.com/mialgae -https://www.instagram.com/mialgae/
Manufacturing
Market Research
Product Design
Biotechnology
Prediction Markets
Agriculture

2016

Pushing boundaries to drive Impact! Championing the future of protein through microorganisms Building Smaller, Better, Faster Hamburg & Lisbon Join us, we are hiring!
Biotechnology

2021

Our mission at MiroBio is to deliver transformational immunotherapies for people suffering from autoimmune disease. Immune imbalance is at the heart of many conditions which are marked by an attack on the body’s own cells. MiroBio is advancing a new class of therapies designed to restore immune balance – or homeostasis – and potentially provide durable remission from these chronic, complex conditions. To achieve this, MiroBio has built deep expertise in an emerging area of immunology: precise activation of inhibitory pathways to restore healthy immune function. Our pipeline of agonistic antibodies and supporting platform are informed by over a decade of foundational research. MiroBio draws upon a transatlantic team of advisers, drug developers and leading healthcare investors to further its leadership in this vast new area of immunology.
Biotechnology
Life Science

2019

Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a global team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.
Biotechnology

2019

Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
Health Centers
Medical Equipment and Services
Health and Medical Products
Personal Health
Healthcare
Bioinformatics
Biotechnology

2022

Mission NMD Pharma is dedicated to developing novel treatments to improve muscle function and quality of life of patients with neuromuscular disease. Vision A future in which patients with neuromuscular disease live better and more independent lives. We have a unique translational muscle electrophysiology platform leveraging in-depth know-how of muscle physiology and muscular disorders for discovering and developing first-in-class therapeutics in neuromuscular diseases with a significant unmet medical need. NMD Pharma is the leading company utilizing ClC-1 Cl- ion channel inhibitors for neuromuscular diseases and currently has one clinical-stage product candidate for the treatment of myasthenia gravis. We have more than 25 employees with expertise in all areas of drug development. We are headquartered in Aarhus, Denmark, and collaborate with internationally renowned companies and key opinion leaders in the field of neuromuscular diseases. For more information, please visit the company website.
Medical
Pharmaceutical
Biotechnology

2015

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 90% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. The Company has the unique ability to link these variants to gene function and precisely map disease pathways. Nucleome’s cell type-specific platform creates high resolution 3D genome structure maps and enables variant functional validation at scale in primary cell types, enabling the discovery and development of novel, better and safer drugs. The initial focus of the company is on lymphocytes and related autoimmune disease. Nucleome’s ambition is to build a robust pipeline of drug assets, with corresponding biomarkers. Nucleome Therapeutics was founded by leading experts in gene regulation from the University of Oxford. For more information, please visit www.nucleome.com.
Biotechnology
Therapeutics
Genetics

2019

We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
Manufacturing
Pharmaceutical
Biotechnology

2015

Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
Biopharma
Healthcare
Biotechnology
Therapeutics

2019

ONA Therapeutics is a biotech company, spin-off of ICREA and IRB, specializes in unravelling novel biology to design biopharmaceuticals attacking advanced cancer.
Healthcare
Biotechnology
Life Science

2019

Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients. Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer. Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers. Oncoinvent – Innovations for better cancer care.
Pharmaceutical
Biotechnology
Life Science

2010

List of Biotechnology companies in Europe

Company Name

Location

Category

Employees

Website

Glasgow, United Kingdom (UK)

Information Technology
+1
Information Technology, Science and Engineering

10-20

https://www.biomage.net/

Vienna, Austria

Food and Beverages
+2
Food and Beverages, Science and Engineering, Agriculture and Livestock

10-20

https://www.blueplanetecosystems.com/

Edinburgh, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://www.enterobiotix.com/

Milan, Italy

Manufacturing and Industry
+2
Manufacturing and Industry, Health and Medical, Science and Engineering

2-10

https://www.entherapharmaceuticals.com/

London, United Kingdom (UK)

Science and Engineering
+2
Science and Engineering, Energy, Agriculture and Livestock

20-30

https://entocycle.com/

Lausanne, Switzerland

Information Technology
+1
Information Technology, Science and Engineering

10-20

https://bionomous.ch/

Zurich, Switzerland

Science and Engineering
Science and Engineering

2-10

https://www.recolony.ch/

Berlin, Germany

Food and Beverages
+1
Food and Beverages, Science and Engineering

10-20

https://www.bosquefoods.com/

Belfast, United Kingdom (UK)

Beauty and Personal Care
+3
Beauty and Personal Care, Sport and Recreation, Health and Medical, Science and Engineering

30-50

https://www.cumulusneuro.com/

Hamburg, Germany

Science and Engineering
Science and Engineering

2-10

https://breakpointtx.com/

Cambridge, United Kingdom (UK)

Information Technology
+1
Information Technology, Science and Engineering

10-20

https://www.cardiatec.ai/

Cambridge, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

https://www.crescendobiologics.com/

Edinburgh, United Kingdom (UK)

Information Technology
+2
Information Technology, Health and Medical, Science and Engineering

20-30

https://www.cytomos.com/

Warsaw, Poland

Information Technology
+1
Information Technology, Science and Engineering

2-10

https://www.deepflare.ai/

Rotterdam, The Netherlands

Science and Engineering
Science and Engineering

30-50

https://www.deltadiagnostics.nl/

Zug, Switzerland

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.demiurge.technology/

Copenhagen, Denmark

Professional Services
+2
Professional Services, Health and Medical, Science and Engineering

10-20

https://afyxtx.com/

Pessac, France

Manufacturing and Industry
+2
Manufacturing and Industry, Health and Medical, Science and Engineering

10-20

https://www.emulseo.com/

Paris, France

Clothing and Accessories
+4
Clothing and Accessories, Creative and Entertainment, Manufacturing and Industry, Energy, Science and Engineering

30-50

https://www.faircraft.bio/

Dublin, Ireland

Health and Medical
+1
Health and Medical, Science and Engineering

100-150

https://fire1foundry.com/

Galway, Ireland

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

http://www.kitemedical.ie/

Vienna, Austria

Food and Beverages
+2
Food and Beverages, Environment, Science and Engineering

10-20

https://www.livinfarms.com/

Geneva, Switzerland

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.calliditas.se/en/

Rome, Italy

Information Technology
+2
Information Technology, Health and Medical, Science and Engineering

30-50

https://www.juliaomix.com/

Dublin, Ireland

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://www.ghres.com/

Geneva, Switzerland

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://new.gliapharm.com/

Nantes, France

Science and Engineering
Science and Engineering

2-10

https://golivertx.com/

Nantes, France

Science and Engineering
Science and Engineering

30-50

https://www.i-sep.com/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://lightcastd.com/

Hamburg, Germany

Manufacturing and Industry
+1
Manufacturing and Industry, Science and Engineering

10-20

https://www.lignopure.com/

Strasbourg, France

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://cardio-renal.com/

Lund, Sweden

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

https://ziccum.com/

Wädenswil, Switzerland

Science and Engineering
Science and Engineering

50-100

https://www.numab.com/

Galway, Ireland

Health and Medical
+1
Health and Medical, Science and Engineering

10-20

https://www.luminatemed.com/

Dublin, Ireland

Health and Medical
+1
Health and Medical, Science and Engineering

150-200

https://mainstaymedical.com/

Geneva, Switzerland

Science and Engineering
Science and Engineering

10-20

http://www.maxivax.ch/home/

Milan, Italy

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://www.medicilio.it/

Lyon, France

Information Technology
+3
Information Technology, Health and Medical, Business Services, Science and Engineering

50-100

http://www.medicrea.com/

Madrid, Spain

Health and Medical
+3
Health and Medical, Business Services, Information Technology, Science and Engineering

30-50

https://www.medlumics.com/

Edinburgh, United Kingdom (UK)

Manufacturing and Industry
+5
Manufacturing and Industry, Sales and Marketing, Design Services, Science and Engineering, Finance and Banking, Agriculture and Livestock

30-50

https://www.mialgae.com/

Hamburg, Germany

Science and Engineering
Science and Engineering

20-30

https://microharvest.com/

Oxford, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.mirobio.com/

Paris, France

Science and Engineering
Science and Engineering

30-50

https://www.mnemo-tx.com/

Zurich, Switzerland

Health and Medical
+1
Health and Medical, Science and Engineering

2-10

https://www.navignostics.com/

Aarhus, Denmark

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://www.nmdpharma.com/

Oxford, United Kingdom (UK)

Science and Engineering
+1
Science and Engineering, Health and Medical

30-50

https://nucleome.com/

Düsseldorf, Germany

Manufacturing and Industry
+2
Manufacturing and Industry, Health and Medical, Science and Engineering

10-20

https://numaferm.com/

Oxford, United Kingdom (UK)

Health and Medical
+1
Health and Medical, Science and Engineering

50-100

https://www.ochre-bio.com/

Barcelona, Spain

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://ona-therapeutics.com/

Oslo, Norway

Health and Medical
+1
Health and Medical, Science and Engineering

30-50

https://www.oncoinvent.com/

350/480 results

Frequently asked questions

Updated 23 October 2026

What is Enterprise League?

Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.

Is it free to list my company?

Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.

How does verification work, and what does it cost?

Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.

Where does the company information come from?

Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.

How do I claim or correct my company’s profile?

Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.